Ironwood Pharma Inc Class A (IRWD)
$3.50 -3.31% Close Oct 30, 2026 Live
Ironwood Pharma stock today
Ironwood Pharma closed at $3.50 on October 30, 2026, down 3.31% on the day. Over the past year it returned +133.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $576 million.
$2.00$4.00
NovJan 2026MarMayJulSep
| Period | IRWD | S&P 500 (SPY) |
|---|---|---|
| 1 month | -11.8% | -0.9% |
| 3 months | -6.2% | +2.1% |
| Year to date | +3.9% | +11.7% |
| 1 year | +133.3% | +12.4% |
| 3 years | -60.8% | +88.5% |
| 5 years | -72.6% | +76.0% |
Key statistics
- Market value
- $576M
- P/E (trailing)
- 4.6
- Forward P/E
- 2.6
- Price / sales
- 1.5
- 52-week range
- $1.50 to $5.39
- Next report
- Nov 5, 2026
About Ironwood Pharma
Develops and commercializes gastrointestinal pharmaceutical treatments.
Sector: Health Care
More on Ironwood Pharma
- Financials: revenue, earnings and segmentsRevenue -16% in the year to Dec 2025
- Valuation: P/E history and peersP/E 4.6, median 17.3 at its last 5 year ends
- Returns: what $1,000 became$1,000 ten years ago is $265.35 today
No forecast, no recommendation. This page describes Ironwood Pharma Inc Class A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.